Skip to content

Insulet PODD Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Medtronic logo
MedtronicMDT
$123M-66.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$4.48M+517%
Viatris logo
ViatrisVTRS
$32.7M-67.8%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's change in AP?
Insulet (PODD) reported change in AP of $71.4M in Q1 2026.
How has Insulet's change in AP changed year-over-year?
Insulet's change in AP increased by 95.6% year-over-year, from $36.5M to $71.4M.
What is the long-term trend for Insulet's change in AP?
Over 2 years (2021 to 2023), Insulet's change in AP has grown at a -16.0% compound annual growth rate (CAGR), from -$15.6M to -$11M.
What does change in AP mean?
The net change in the amount of money the company owes to its suppliers.
How do you interpret change in AP?
An increase indicates the company is retaining cash longer, while a decrease indicates faster settlement of liabilities.
How does change in AP compare across companies?
Standard working capital metric; peers in the medical device sector manage this to optimize cash conversion cycles.